About
Medicine that looks beyond the label.
Founded in Pune in 2020 to treat the cause of metabolic disease rather than manage its symptoms.
“I don’t treat your blood sugar number. I treat the person whose life that number affects.”
Dr. Zaid Khan
Founder & Clinical Lead
A metabolic health and lifestyle medicine specialist with fifteen years of practice and advanced training across India and Singapore.
- MBBS
- MD (Internal Medicine)
- Metabolic Medicine Fellowship
- CGM Certified
- RSSDI Active Member
How we practise
Three rules we never break.
Root cause thinking
No symptom is suppressed before its origin is understood.
Data-guided decisions
CGM traces and full metabolic panels drive every clinical call — not guesswork.
Lifelong partnership
Metabolic health is a direction, not a destination. We stay for the long arc.
The path here
Seventeen years, one question.
Why does the same treatment work for one patient and not another?
2008
MBBS
Graduated with distinction from a leading Maharashtra medical school.
2012
MD — Internal Medicine
Residency focused on complex endocrine cases.
2014
Metabolic Medicine Fellowship
Trained under metabolic specialists in India and Singapore.
2016
CGM & Insulin Pump Certification
Certified trainer for FreeStyle Libre and Dexcom systems.
2018
Lifestyle Medicine Certification
Certified in evidence-based reversal of chronic disease.
2020
Rhiverse founded
A dedicated metabolic practice opens in Pune.
2023
Published research
Peer-reviewed work on CGM use in non-diabetic populations.
2025
Today
A growing specialist team and more than 500 patients.
Treatment options
Modern metabolic therapies.
Used when clinically indicated — always alongside lifestyle medicine, never instead of it.
GLP-1 therapies
Improve glucose control and appetite regulation through gut–brain signalling.
Dual GIP/GLP-1
Next-generation dual agonists acting on two complementary metabolic pathways.
Medical weight management
Structured programmes pairing pharmacotherapy with continuous monitoring.
Research & education
Evidence-driven practice.
RSSDI
Active membership of the Research Society for the Study of Diabetes in India keeps the practice current with the evidence it is built on.
- Annual conference
- Peer review
- Guideline updates
CGM in non-diabetic populations
Metabolic variability in people without a diabetes diagnosis.
Insulin resistance reversal
Restoring insulin sensitivity and metabolic flexibility.
Metabolic phenotyping
Distinct metabolic subtypes as the basis for personalised treatment.
GLP-1 in South Asian T2D
Outcomes of GLP-1 and dual agonists in South Asian patients.
PCOS metabolic framework
PCOS as a primary metabolic disorder, not a reproductive one.
Ready to understand your metabolic health?
One conversation can change how you read your own body.